| | Cardiology.doc | 466.5 KB |
| | Chest pain assessment of patients with suspected cardiac chest pain.mht | 20.23 KB |
| | Atrial fibrillation anticoagulation.mht | 19.93 KB |
| | Acute coronary syndrome management.mht | 19.55 KB |
| | Cardiac imaging non-invasive techniques excluding echocardiography.mht | 18.8 KB |
| | Angina pectoris drug management.mht | 18.49 KB |
| | Electrical activity of the heart.mht | 18.22 KB |
| | Long QT syndrome.mht | 18.17 KB |
| | Atrial fibrillation rate control and maintenance of sinus rhythm.mht | 18.17 KB |
| | Myocardial infarction management.mht | 18.05 KB |
| | Clinical Hematology and Oncology.doc | 150 KB |
| | Polycythaemia rubra vera - features.mht | 20.13 KB |
| | Palliative care prescribing - pain.mht | 18.36 KB |
| | Cytotoxic agents.mht | 18.27 KB |
| | Haemochromatosis - investigation.mht | 17.6 KB |
| | Paroxysmal nocturnal haemoglobinuria.mht | 17.54 KB |
| | Tumour markers.mht | 17.5 KB |
| | Antiphospholipid syndrome.mht | 17.49 KB |
| | Von Willebrand's Disease.mht | 17.38 KB |
| | Monoclonal Antibodies.mht | 17.37 KB |
| | Clinical Hematology and Oncology.doc | 150 KB |
| | Polycythaemia rubra vera - features.mht | 20.13 KB |
| | Palliative care prescribing - pain.mht | 18.36 KB |
| | Cytotoxic agents.mht | 18.27 KB |
| | Haemochromatosis - investigation.mht | 17.6 KB |
| | Paroxysmal nocturnal haemoglobinuria.mht | 17.54 KB |
| | Tumour markers.mht | 17.5 KB |
| | Antiphospholipid syndrome.mht | 17.49 KB |
| | Von Willebrand's Disease.mht | 17.38 KB |
| | Monoclonal Antibodies.mht | 17.37 KB |
| | Clinical pharmacology and toxicology.doc | 573.5 KB |
| | Osteoporosis secondary prevention.mht | 24.05 KB |
| | Acute coronary syndrome- management.mht | 19.55 KB |
| | Statins.mht | 19.07 KB |
| | Smoking Cessation.mht | 18.68 KB |
| | Diabetes mellitus GLP-1 and the new drugs.mht | 18.68 KB |
| | Parkinson's disease -management.mht | 18.5 KB |
| | Palliative care prescribing - pain.mht | 18.36 KB |
| | Cytotoxic agents.mht | 18.27 KB |
| | Long QT syndrome.mht | 18.18 KB |
| | Clinical sciences.doc | 725 KB |
| | Menstrual cycle.mht | 19.33 KB |
| | Cardiac imaging - non-invasive techniques excluding echocardiography.mht | 18.8 KB |
| | Vitamin deficiency.mht | 18.71 KB |
| | Diabetes mellitus GLP-1 and the new drugs.mht | 18.68 KB |
| | Foramina of the skull.mht | 18.62 KB |
| | Gastrointestinal hormones.mht | 18.6 KB |
| | Electrical activity of the heart.mht | 18.22 KB |
| | Long QT syndrome.mht | 18.18 KB |
| | Colorectal cancer -genetics.mht | 18.07 KB |
| | dermatology.doc | 293.5 KB |
| | Skin disorders associated with malignancy.mht | 18.7 KB |
| | Eczema - topical steroids.mht | 18.38 KB |
| | scabies.mht | 18.37 KB |
| | Polycystic ovarian syndrome- management.mht | 17.82 KB |
| | psoriasis.mht | 17.73 KB |
| | Shin lesions.mht | 17.63 KB |
| | Hirsuitism and hypertrichosis.mht | 17.58 KB |
| | Tinea.mht | 17.54 KB |
| | Acne vulgaris - management.mht | 17.4 KB |
| | Endocrinology.doc | 325 KB |
| | Diabetes mellitus- management of type 2.mht | 19.68 KB |
| | Diabetic retinopathy.mht | 18.9 KB |
| | Diabetes mellitus GLP-1 and the new drugs.mht | 18.68 KB |
| | Metabolic syndrome.mht | 18.58 KB |
| | Pregnancy - diabetes mellitus.mht | 18.26 KB |
| | Glycosylated haemoglobin.mht | 18.25 KB |
| | Obesity - bariatric surgery.mht | 18.13 KB |
| | Myocardial infarction management.mht | 18.05 KB |
| | Thyroid function tests.mht | 17.86 KB |
| | Hepatitis B.mht | 19.56 KB |
| | GASTROENTERITIS.mht | 18.84 KB |
| | Skin disorders associated with malignancy.mht | 18.7 KB |
| | Dysphagia.mht | 18.23 KB |
| | Coeliac disease.mht | 18.2 KB |
| | Irritable bowel syndrome management.mht | 18.08 KB |
| | Colorectal cancer genetics.mht | 18.07 KB |
| | Dyspepsia.mht | 17.74 KB |
| | Oesophageal varices.mht | 17.64 KB |
| | Haemochromatosis investigation.mht | 17.6 KB |
| | Hepatitis B.mht | 19.56 KB |
| | GASTROENTERITIS.mht | 18.84 KB |
| | Skin disorders associated with malignancy.mht | 18.7 KB |
| | Dysphagia.mht | 18.23 KB |
| | Colorectal cancer genetics.mht | 18.07 KB |
| | Oesophageal varices.mht | 17.64 KB |
| | Haemochromatosis investigation.mht | 17.6 KB |
| | Child-Pugh classification of liver cirrhosis.mht | 17.54 KB |
| | Clostridium difficile.mht | 17.39 KB |
| | Hepatocellular carcinoma.mht | 17.32 KB |
| | Hepatitis B.mht | 19.56 KB |
| | GASTROENTERITIS.mht | 18.84 KB |
| | chlamydia.mht | 18.84 KB |
| | scabies.mht | 18.37 KB |
| | HIV and pregnancy.mht | 18.07 KB |
| | mrsa.mht | 17.81 KB |
| | HIV - neurocomplications.mht | 17.71 KB |
| | chickenpox.mht | 17.69 KB |
| | Tuberculosis skin tests.mht | 17.65 KB |
| | Meningitis- CSF analysis.mht | 17.6 KB |
| | Palliative care prescribing - pain.mht | 18.36 KB |
| | Chronic kidney disease -proteinuria.mht | 17.98 KB |
| | Acute renal failure acute tubular necrosis vs. Prerenal uraemia.mht | 17.95 KB |
| | Gout - management.mht | 17.91 KB |
| | Renal stones -imaging.mht | 17.76 KB |
| | Chronic kidney disease- eGFR and classification.mht | 17.75 KB |
| | Haematuria.mht | 17.52 KB |
| | Glomerulonephritides.mht | 17.42 KB |
| | IgA nephropathy.mht | 17.25 KB |
| | Chronic kidney disease - hypertension.mht | 17.23 KB |
| | visual fields.gif | 116.54 KB |
| | Transient ischaemic attack.mht | 19.37 KB |
| | Stroke management.mht | 18.68 KB |
| | Parkinson's disease management.mht | 18.49 KB |
| | Migraine- diagnostic criteria.mht | 18.32 KB |
| | Migraine management.mht | 18.06 KB |
| | HIV - neurocomplications.mht | 17.71 KB |
| | Meningitis -CSF analysis.mht | 17.6 KB |
| | Multiple sclerosis - management.mht | 17.49 KB |
| | Post-lumbar puncture headache.mht | 17.48 KB |
| | Sudden painless loss of vision.mht | 19.23 KB |
| | Diabetic retinopathy.mht | 18.9 KB |
| | Age related macular degeneration.mht | 18.43 KB |
| | Primary open-angle glaucoma management.mht | 18.18 KB |
| | BLEPHARITIS.mht | 17.4 KB |
| | Temporal arteritis.mht | 17.25 KB |
| | Horner's syndrome.mht | 17.12 KB |
| | Thyroid eye disease.mht | 16.95 KB |
| | Acute angle closure glaucoma.mht | 16.94 KB |
| | Marfan's syndrome.mht | 16.88 KB |
| | Depression - selective serotonin reuptake inhibitors.mht | 18.52 KB |
| | Post-partum mental health problems.mht | 17.72 KB |
| | Post-traumatic stress disorder.mht | 17.61 KB |
| | Schizophrenia features.mht | 17.42 KB |
| | Unexplained symptoms.mht | 17.35 KB |
| | Benzodiazepines.mht | 17.27 KB |
| | Atypical antipsychotics.mht | 17.27 KB |
| | Parkinson's disease- features.mht | 16.99 KB |
| | Tricyclic antidepressants.mht | 16.98 KB |
| | Antipsychotics.mht | 16.98 KB |
| | Asthma- stepwise management in adults.mht | 19.39 KB |
| | Asthma- diagnosis in adults.mht | 19.09 KB |
| | Parkinson's disease management.mht | 18.5 KB |
| | COPD- stable management.mht | 18.32 KB |
| | COPD- investigation and diagnosis.mht | 18.18 KB |
| | Fitness to fly.mht | 17.93 KB |
| | Pulmonary embolism investigation.mht | 17.9 KB |
| | Pulmonary embolism management.mht | 17.87 KB |
| | Asthma- acute severe.mht | 17.48 KB |
| | Pneumothorax.mht | 17.39 KB |
| | Elbow pain.mht | 18.45 KB |
| | Rheumatoid arthritis management.mht | 17.91 KB |
| | Gout management.mht | 17.91 KB |
| | CHRONIC FATIGUE SYNDROME.mht | 17.78 KB |
| | methotrexate.mht | 17.75 KB |
| | Osteoarthritis management.mht | 17.57 KB |
| | Tumour necrosis factor.mht | 17.54 KB |
| | Antiphospholipid syndrome.mht | 17.49 KB |
| | Reactive arthritis.mht | 17.42 KB |
| | Ankylosing spondylitis investigation and management.mht | 17.37 KB |